Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
insitro
Overview
insitro is a pioneering data-driven drug discovery and development company leveraging machine learning, particularly deep learning, and high-throughput experimental biology to revolutionize pharmaceutical research and development. Operating within the biotechnology and pharmaceutical sectors, insitro focuses on creating predictive models of human disease biology to identify novel therapeutic targets, optimize drug candidates, and improve clinical trial outcomes. By integrating advanced computational methods with cutting-edge biological data generation, insitro aims to significantly improve the efficiency and success rates of drug development, positioning itself as a leader in the emerging field of AI-driven drug discovery and a valuable partner for established pharmaceutical companies seeking to accelerate and de-risk their pipelines.
insitro's headcount breakdown by department
| Department | HeadCount |
|---|---|
Administrative | 9 |
Consulting | 1 |
Service | 1 |
Design | 0 |
Education | 0 |
The department distribution at insitro paints a clear picture of a company deeply rooted in research and development, driven by a technologically advanced approach to drug discovery. The substantial proportion of employees in 'Research' (73) and 'Technical' (56) roles underscores the company's commitment to scientific innovation and the development of its proprietary machine learning platform, insitroOS. The 'Other Department' count (78), being the largest, likely encompasses specialized scientists, engineers, and computational biologists involved in various aspects of data generation, model building, and validation. The comparatively small sizes of 'Sales' (3) and 'Marketing' (1) departments suggest that insitro's business model relies heavily on strategic partnerships and scientific validation to drive adoption and collaboration, rather than aggressive direct sales, a common approach for early-stage, platform-focused biotech companies. The presence of 'Finance' (17), 'HR' (13), 'Operations' (9), 'Legal' (4), and 'General Management' (14) indicates a maturing organization with the necessary infrastructure to support its core research activities. The minimal presence in 'Customer Service' (1) and 'Consulting' (1) roles further validates a B2B model centered on collaborative drug discovery with major pharmaceutical players, rather than direct consumer products or extensive training programs. The lack of employees in 'Design' and 'Education' departments confirms that insitro is not focused on product design as a core service offering or on providing educational programs around their technology, but rather on scientific innovation and drug discovery.
insitro's employees by locations
Employee Count by Country
Total: 286 employees
insitro's workforce is overwhelmingly concentrated in the United States (276 out of 279 employees), indicating a primarily domestic operational strategy. This high concentration reflects the company's Silicon Valley headquarters and the strategic importance of being located within a hub of innovation, talent, and capital within the US biotechnology and technology sectors. The limited international footprint, with single-digit employees in Canada (1), Nigeria (1), Democratic Republic of the Congo (1), United Arab Emirates (1), United Kingdom (2), and Poland (4), suggests a nascent stage of international expansion or targeted hiring of specialized expertise, possibly in computational biology or data science, outside the US. This predominantly domestic focus aligns with insitro's current business model, which emphasizes advanced research and development and collaborative partnerships with major pharmaceutical companies. By leveraging established global pharmaceutical infrastructure for clinical trials and market access, insitro can minimize the immediate need for a widespread global workforce. As the company matures, its pipeline progresses, and it potentially seeks to establish a more independent drug development and commercialization pathway, a more diversified international presence could become necessary to support clinical trials in diverse populations and potential market entry into new regions, especially in Europe and Asia.
Want to stay ahead of insitro's org changes?
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early